P Maxwell

2.0k total citations
40 papers, 1.5k citations indexed

About

P Maxwell is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, P Maxwell has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in P Maxwell's work include Cancer and Skin Lesions (5 papers), Skin and Cellular Biology Research (4 papers) and Cancer-related Molecular Pathways (4 papers). P Maxwell is often cited by papers focused on Cancer and Skin Lesions (5 papers), Skin and Cellular Biology Research (4 papers) and Cancer-related Molecular Pathways (4 papers). P Maxwell collaborates with scholars based in United Kingdom, Ireland and Bangladesh. P Maxwell's co-authors include W. Glenn McCluggage, Vaiyapuri P. Sumathi, P. G. Toner, Patrick G. Johnston, M K Heatley, James M. Sloan, David Waugh, Catherine Wilson, David Jenkins and Roy Cameron and has published in prestigious journals such as Oncogene, Annals of Surgery and British Journal of Cancer.

In The Last Decade

P Maxwell

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Maxwell United Kingdom 22 451 431 320 296 289 40 1.5k
Kristen A. Atkins United States 24 574 1.3× 412 1.0× 353 1.1× 301 1.0× 354 1.2× 71 1.8k
Mark Messing United States 13 420 0.9× 261 0.6× 225 0.7× 478 1.6× 306 1.1× 31 1.1k
Takeo Minaguchi Japan 26 490 1.1× 648 1.5× 229 0.7× 323 1.1× 368 1.3× 54 1.7k
Toshihiko Toki Japan 25 352 0.8× 417 1.0× 572 1.8× 584 2.0× 776 2.7× 67 2.0k
Beatriz Lifschitz‐Mercer Israel 21 248 0.5× 389 0.9× 499 1.6× 228 0.8× 113 0.4× 73 1.5k
Uta Reichelt Germany 24 710 1.6× 419 1.0× 224 0.7× 109 0.4× 92 0.3× 47 1.4k
Fılız Bolat Türkiye 18 219 0.5× 213 0.5× 257 0.8× 153 0.5× 127 0.4× 80 1.1k
Kazuhiro Takehara Japan 24 461 1.0× 305 0.7× 531 1.7× 805 2.7× 736 2.5× 133 1.8k
Deyin Xing United States 25 861 1.9× 1.1k 2.6× 436 1.4× 282 1.0× 167 0.6× 102 2.4k
Najmosama Nikrui United States 18 347 0.8× 336 0.8× 205 0.6× 887 3.0× 641 2.2× 33 1.6k

Countries citing papers authored by P Maxwell

Since Specialization
Citations

This map shows the geographic impact of P Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Maxwell more than expected).

Fields of papers citing papers by P Maxwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Maxwell. The network helps show where P Maxwell may publish in the future.

Co-authorship network of co-authors of P Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of P Maxwell. A scholar is included among the top collaborators of P Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Maxwell. P Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sawair, Faleh, Yazan Hassona, C. Irwin, et al.. (2016). p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence. Asian Pacific Journal of Cancer Prevention. 17(3). 1243–1249. 9 indexed citations
2.
Gray, Ronan T., Mark E. O’Donnell, Rejina Verghis, et al.. (2012). Bone marrow micrometastases in esophageal carcinoma: a 10-year follow-up study. Diseases of the Esophagus. 25(8). 709–715. 8 indexed citations
3.
Zawiślak, Agnieszka, Ryan F. Donnelly, W. Glenn McCluggage, et al.. (2009). Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid. Photodiagnosis and Photodynamic Therapy. 6(1). 28–40. 25 indexed citations
4.
Seaton, Angela, P Maxwell, A Hill, et al.. (2009). Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells. British Journal of Cancer. 101(9). 1620–1629. 10 indexed citations
5.
Wilson, Catherine, P. Scullin, Jenny Worthington, et al.. (2008). Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer. British Journal of Cancer. 99(12). 2054–2064. 27 indexed citations
6.
Maxwell, P, Ryan S. Gallagher, Angela Seaton, et al.. (2007). HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene. 26(52). 7333–7345. 169 indexed citations
7.
Woltering, Eugene A., James M. Lewis, P Maxwell, et al.. (2003). Development of a Novel In Vitro Human Tissue-Based Angiogenesis Assay to Evaluate the Effect of Antiangiogenic Drugs. Annals of Surgery. 237(6). 790–800. 28 indexed citations
8.
Heatley, M K, et al.. (2002). Vimentin expression does not assist in predicting survival in ductal carcinoma of the breast. Pathology. 34(3). 230–232. 12 indexed citations
9.
Graham, Alastair N.J., et al.. (2002). Increased nm23 immunoreactivity is associated with selective inhibition of systemic tumour cell dissemination. Journal of Clinical Pathology. 55(3). 184–189. 5 indexed citations
11.
Cruz, I, S. Napier, I. van der Waal, et al.. (2002). Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. Journal of Clinical Pathology. 55(2). 98–104. 68 indexed citations
12.
Mullan, Robert, P Maxwell, David Simpson, et al.. (2001). Characterization and localization of expression of an erythropoietin‐induced gene, ERIC‐1/TACC3, identified in erythroid precursor cells. British Journal of Haematology. 112(4). 1016–1024. 31 indexed citations
13.
McCluggage, W. Glenn & P Maxwell. (2001). Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord–stromal tumours. Histopathology. 38(5). 403–408. 91 indexed citations
14.
McCluggage, W. Glenn, et al.. (2001). Monoclonal antibody SM047 as an immunohistochemical marker of ovarian adenocarcinoma. Histopathology. 38(6). 542–549. 4 indexed citations
15.
Maxwell, P, et al.. (2000). Audit and internal quality control in immunohistochemistry. Journal of Clinical Pathology. 53(12). 929–932. 23 indexed citations
17.
Heaney, Liam G., et al.. (1997). A comparison of three standard methods of identifying mast cells in endobronchial biopsies in normal and asthmatic subjects. Allergy. 52(8). 836–843. 5 indexed citations
18.
McCluggage, W. Glenn, et al.. (1997). Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin. Histopathology. 30(6). 518–522. 32 indexed citations
19.
McCluggage, W. Glenn, Damian McManus, P Maxwell, & Maie Walsh. (1996). T-cell-rich histiocyte-rich B-Cell lymphoma of parotid gland. The Journal of Laryngology & Otology. 110(8). 811–813. 3 indexed citations
20.
McManus, Damian, Eric P.H. Yap, P Maxwell, et al.. (1994). p53 Expression, mutation, and allelic deletion in ovarian cancer. The Journal of Pathology. 174(3). 159–168. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026